Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Arterial Hypertension

Explore clinical trials studying Pulmonary Arterial Hypertension. Study availability and eligibility vary by location and protocol.

354 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Arterial Hypertension trial results

Completed

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

NCT01392469

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Novartis Investigative Site Tampa, Florida, United States
  • Novartis Investigative Site Weston, Florida, United States
  • Novartis Investigative Site Mineola, New York, United States
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
View Trial Details
Completed

An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension

NCT01027949

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • The Kirklin Clinic Birmingham, Alabama, United States
  • Arizona Pulmonary Specialists, Ltd. Phoenix, Arizona, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 134 locations
View Trial Details
Completed

Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH

NCT03888365

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars-Sinai Medical Center Beverly Hills, California, United States
  • Santa Barbara Pulmonary Associates Santa Barbara, California, United States
  • St. Francis Sleep, Allergy & Lung Institute Clearwater, Florida, United States
View Trial Details
Completed

A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children

NCT00159874

Conditions
Hypertension, Pulmonary, Lung Diseases, Pulmonary Arterial Hypertension, +1 more
Locations
  • Pfizer Investigational Site Palo Alto, California, United States
  • Pfizer Investigational Site Palo Alto, California, United States
  • Pfizer Investigational Site Stanford, California, United States
  • Pfizer Investigational Site Aurora, Colorado, United States
View all 39 locations
View Trial Details
Completed

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

NCT01642407

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
Locations
  • Kitasato University Hospital Sagamihara, Kanagawa, Japan
  • Osaka University Hospital Suita, Osaka, Japan
  • Toho University Omori Medical Center Ōta-ku, Tokyo, Japan
  • National Center for Child Health and Development Setagaya-ku, Tokyo, Japan
View Trial Details

Related conditions